Charlotte's Web Holdings (CWBHF) Depreciation & Amortization (CF) (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Depreciation & Amortization (CF) of $1.7 million for Q1 2026, down 31.48% year-over-year from $2.4 million in Q1 2025, and little changed quarter-over-quarter from $1.7 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 31.48% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $5.6 million (down 44.12% YoY), while the FY2025 annual figure was $6.3 million, down 36.64% from the prior year.
- Depreciation & Amortization (CF) held at $1.7 million in Q1 2026 per CWBHF's latest filing, from $1.7 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $4.0 million in Q2 2023 and bottomed at $512000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $2.5 million across 5 years, with a median of $2.5 million in 2024.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 113.59% — and 2025, when it tumbled 79.43%.
- Charlotte's Web Holdings' Depreciation & Amortization (CF) stood at $3.2 million in 2022, then climbed by 13.88% to $3.7 million in 2023, then plunged by 32.24% to $2.5 million in 2024, then tumbled by 32.38% to $1.7 million in 2025, then climbed by 0.3% to $1.7 million in 2026.
- Business Quant data shows CWBHF's Depreciation & Amortization (CF) at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Charlotte's Web Holdings | 62.78 Mn | 48.79 Mn | 5.16 Mn | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 512,000.00 |
| Jun 30, 2025 | 512,000.00 |
| Mar 31, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |